[go: up one dir, main page]

WO2009140279A3 - Sulfonyl urea compounds - Google Patents

Sulfonyl urea compounds Download PDF

Info

Publication number
WO2009140279A3
WO2009140279A3 PCT/US2009/043629 US2009043629W WO2009140279A3 WO 2009140279 A3 WO2009140279 A3 WO 2009140279A3 US 2009043629 W US2009043629 W US 2009043629W WO 2009140279 A3 WO2009140279 A3 WO 2009140279A3
Authority
WO
WIPO (PCT)
Prior art keywords
urea compounds
sulfonyl urea
compositions
solvates
hydrates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/043629
Other languages
French (fr)
Other versions
WO2009140279A2 (en
Inventor
Scott L. Harbeson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Concert Pharmaceuticals Inc
Original Assignee
Concert Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Concert Pharmaceuticals Inc filed Critical Concert Pharmaceuticals Inc
Publication of WO2009140279A2 publication Critical patent/WO2009140279A2/en
Publication of WO2009140279A3 publication Critical patent/WO2009140279A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention relates to novel sulfonyl ureas, their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering potassium (ATP) channel blockers.
PCT/US2009/043629 2008-05-12 2009-05-12 Sulfonyl urea compounds Ceased WO2009140279A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5244208P 2008-05-12 2008-05-12
US61/052,442 2008-05-12
US5679508P 2008-05-28 2008-05-28
US61/056,795 2008-05-28

Publications (2)

Publication Number Publication Date
WO2009140279A2 WO2009140279A2 (en) 2009-11-19
WO2009140279A3 true WO2009140279A3 (en) 2010-01-14

Family

ID=41319293

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/043629 Ceased WO2009140279A2 (en) 2008-05-12 2009-05-12 Sulfonyl urea compounds

Country Status (1)

Country Link
WO (1) WO2009140279A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9126930B2 (en) 2012-01-06 2015-09-08 Lonza Ltd. Method for preparation of octahydrocyclopenta[c]pyrrole
CN103601666B (en) * 2013-11-28 2015-09-02 遵义医学院 The preparation method of octahydro pentamethylene [C] pyrroles
BR112023020806A2 (en) 2021-04-09 2023-12-12 Immunic Ag DEUTERATE DHODH INHIBITORS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733782B1 (en) * 1999-02-01 2004-05-11 Les Laboratories Servier Core tablet for controlled release of gliclazide after oral administration
US20080089858A1 (en) * 2006-09-15 2008-04-17 Mckittrick Brian A Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733782B1 (en) * 1999-02-01 2004-05-11 Les Laboratories Servier Core tablet for controlled release of gliclazide after oral administration
US20080089858A1 (en) * 2006-09-15 2008-04-17 Mckittrick Brian A Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism

Also Published As

Publication number Publication date
WO2009140279A2 (en) 2009-11-19

Similar Documents

Publication Publication Date Title
WO2008024439A3 (en) 4-aminoquinazoline derivatives and methods of use thereof
WO2005110994A3 (en) Substituted pyrazolyl urea derivatives useful in the treatment of cancer
WO2008050168A8 (en) New sulfonamide derivatives as bradykinin antagonists
MY162936A (en) Macrocycles as factor xia inhibitors
WO2010108074A3 (en) Inhibitors of pi3 kinase
WO2008135826A3 (en) 2 -pyridine carboxamide derivatives as sodium channel modulators
MX2009008531A (en) Nitrogen-containing heterocyclyl ketones and methods of use.
WO2009091374A3 (en) Fused heterocyclic derivatives and methods of use as c-met inhibitors
WO2009108383A3 (en) Substituted xanthine derivatives
WO2009155121A3 (en) Inhibitors of pi3 kinase
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
PH12013500745A1 (en) Azaadamantane derivatives and methods of use
MX2009012168A (en) Pyrrolopyridine derivatives and their use as bace inhibitors.
WO2008079291A3 (en) Substituted heterocycles and methods of use
TW200833675A (en) Nicotinamide derivatives
PT1940839E (en) Pyridopyrimidinone inhibitors of pi3kalpha
MX2013011589A (en) Methods and compositions for treating parkinson's disease.
PT2421879E (en) Novel 7-deazapurine nucleosides for therapeutic uses
PT2310356E (en) Adamantyl diamide derivatives and uses of same
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
TN2012000248A1 (en) Novel spiropiperidine compounds
WO2007150026A3 (en) Purinone derivatives as hm74a agonists
WO2008068540A8 (en) New benzamide derivatives as bradykinin antagonists
MX2013011333A (en) Combinations of akt and mek inhibitor compounds, and methods of use.
PH12015500111A1 (en) Difluorolactam compositions for ep4-mediated osteo related diseases and conditions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09747363

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09747363

Country of ref document: EP

Kind code of ref document: A2